Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Perrigo Campaigns For Rational OTC Shopping Over Brand Loyalty

This article was originally published in The Tan Sheet

Executive Summary

The online “Store Brand Meds” campaign launched by Perrigo in early 2013 encourages consumers to “Make store brands your brand,” by emphasizing lower price points and equivalent active ingredients. Overcoming consumer connections to brands such as Tylenol is a challenge, however.

You may also be interested in...



Study Links Private-Label OTC Purchases To Pharma Knowledge

Physicians and pharmacists are significantly more likely than average consumers to purchase private-label OTC headache remedies, a marketing study finds. The researchers say brands in categories with largely homogenous products may derive premiums through “misinformation” in advertising.

Study Links Private-Label OTC Purchases To Pharma Knowledge

Physicians and pharmacists are significantly more likely than average consumers to purchase private-label OTC headache remedies, a marketing study finds. The researchers say brands in categories with largely homogenous products may derive premiums through “misinformation” in advertising.

J&J OTC Business Returns To Double-Digit U.S. Growth In Q1

The domestic OTC/nutritionals business grew more than 14% in the first quarter on the strength of McNeil products returning to market and a severe cold and flu season. Johnson & Johnson’s consumer performance exceeded some market analyst estimates.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS106428

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel